Compare Mast Therapeutics vs TaiGen Biotechnology
Customers evaluate the quality of Mast Therapeutics's products using the following success metrics.
Overview
Mast Therapeutics is 29 yrs old and is based in United States.
Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candidate, AIR001, is a sodium nitrite solution for intermittent inhalation via nebulization in Phase 2 clinical development for the treatment of HFpEF.
TaiGen Biotechnology is 23 yrs old and is based in Taiwan.
TaiGen Biotechnology (TSEC:4157) specializes in drug development and addressing medical needs. It is a pharmaceutical research and development company that develops anti-infective drugs for multiple diseases. It was founded in 2001 and is based in Taipei City, Taiwan.
Demo Video
Leadership
Carrie McQueen (Chief Financial Officer)
Ming-Chu Hsu (Chief Executive Officer, President)
Investors
Savara, North Sound Capital
MPM Capital, National Development Fund (Taiwan)
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Mast Therapeutics has not claimed their profile.
Work for Mast Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Mast Therapeutics?
Claim your profile now.
Information not available because TaiGen Biotechnology has not claimed their profile.
Work for TaiGen Biotechnology? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for TaiGen Biotechnology?
Claim your profile now.